PROPRANOLOL HYDROCHLORIDE | A071976 | IMPAX LABORATORIES INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Foley & Lardner LLP FDA-2019-P-4515 · 5 docket documents Foley & Lardner LLP filed this citizen petition pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate Propranolol Hydrochloride Tablets USP 80 mg held by Watson Laboratories Inc. (ANDA No. 070178) as an additional reference standard for ANDA submiss | 505(q) | 2019-09-26 | Open | Foley & Lardner LLP |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1644
per ea
Lowest NADAC/Unit
$0.1439
per ea
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69238208101PROPRANOLOL 80 MG TABLET | $0.1644 | EA | Generic | — | 2026-06-17 |
| 69238208105PROPRANOLOL 80 MG TABLET | $0.1644 | EA | Generic | — | 2026-06-17 |
| 69238208001PROPRANOLOL 60 MG TABLET | $0.1439 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.